Close Menu

single-cell analysis

The lawsuit didn't start as a fight between 10x Genomics and Bio-Rad Laboratories, but it will add another chapter to the long feud between them.

Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.

In PNAS this week: homozygous variants linked to mycobacterial disease susceptibility, analysis of the giant axolotl genome, and more.

Starting with genome sequences for thousands of individuals from Alzheimer's-affected families, researchers found rare disease-associated variants at 13 new loci.

In Nature this week: new single-cell RNA sequencing data preprocessing approach, and more.

Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.

In Genome Biology this week: DNA methylation features found among neurodegenerative disorders, analysis of somatic variants in the brain, and more.

In PLOS this week: analysis of differentiating neurons, genome-wide association study of fish oil supplement response, and more.

Earlier this month, GranatumX, which uses a web-based graphical environment, was approved for the Human Cell Atlas Data Portal's analysis tools registry.

The analysis further found that low-risk tumors might develop from cells further along in development, while high-risk ones might develop from earlier-stage cells.


The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.